Copyright
©The Author(s) 2019.
World J Clin Cases. Sep 6, 2019; 7(17): 2438-2449
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2438
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2438
Table 2 Comparison of clinical manifestations between spontaneous fungal peritonitis and fungiascites
Variable | Total (n = 35) | SFP (n = 22) | Fungiascites (n = 13) | P-value |
Antibiotic treatment before peritonitis (d) | 12 (5.0-23.0) | 15.4 (3.8-24.8) | 12.0 (6.0-22.0) | 0.8 |
Anti-fungal therapy | 15 (42.9%) | 8 (36.4%) | 7 (53.8%) | 0.48 |
Septic shock n (%) | 8 (22.9%) | 7 (31.8%) | 1 (4.2%) | 0.21 |
WBC, 109 cells/L (IQR) | 9.4 (5.6-18.1) | 11.7 (8.2-19.1) | 6.8 (3.6-12.0) | 0.046 |
C-reactive protein, mg/L (IQR) | 69.0 (33.3-110.5) | 77.4 (55.9-138.2) | 36.6 (13.4-72.1) | 0.01 |
SIRS n (%) | 19 (54.3%) | 14 (63.6%) | 5 (38.5%) | 0.18 |
Fungus | ||||
Candida spp. | 26 (74.2%) | 18 (81.8%) | 8 (61.5%) | - |
Trichosporon | 2 (5.7%) | 1 (4.5%) | 1 (7.6%) | - |
Aspergillus | 5 (14.3%) | 3 (13.6%) | 2 (15.3%) | - |
Cryptococcus laurentii | 2 (5.7%) | 0 (0%) | 2 (15.3%) | - |
Severity score | ||||
SOFA (M ± SD) | 6.8 ± 3.5 | 7.1 ± 3.8 | 5.2 ± 2.6 | 0.77 |
MELD (IQR) | 14.7 (8.0-24.3) | 15.9 (7.5-25.2) | 14.2 (8.8-24.8) | 0.92 |
CTP (IQR) | 11.0 (9.0-12.0) | 11.0 (8.0-12.3) | 11.0 (9.0-11.5) | 0.7 |
15-d mortality | 13 (37.1%) | 10 (45.1%) | 3 (23.7%) | 0.28 |
- Citation: Huang CH, Pang LT, Xu LC, Ge TT, Xu QM, Chen Z. Risk factors, clinical features, and short-term prognosis of spontaneous fungal peritonitis in cirrhosis: A matched case-control study. World J Clin Cases 2019; 7(17): 2438-2449
- URL: https://www.wjgnet.com/2307-8960/full/v7/i17/2438.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i17.2438